Reporting clinical trials: Why one plus one does not equal two

Journal of the American Academy of Dermatology

Volumn 61, Issue 6, 2009, Pages 1082-1083

  Katz, Kenneth A ^a   Kim, Clara Y ^a   Williams, Hywel C ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DATA ANALYSIS; HYPOTHESIS; LETTER; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VALIDITY;

ACNE VULGARIS; DATA INTERPRETATION, STATISTICAL; HUMANS; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 71549155279     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.077     Document Type: Letter

References (7)

1. Thiboutot D., Zaenglein A., Weiss J., Webster G., Calvarese B., and Chen D. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol 59 (2008) 792-800
2. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for industry: Providing clinical evidence of effectiveness for human drug and biological products, May 1998. Available at: http://www.fda.gov/cder/guidance/1397fnl.pdf. Accessed August 6, 2009.
3. US National Library of Medicine Web site. Daily Med current medication information. Bethesda, MD: US National Library of Medicine. Available at: http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id = 8909. Accessed August 6, 2009.
4. Egger M., Smith G.D., and Phillips A.N. Meta-analysis: principles and procedures. BMJ 315 (1997) 1533-1537
5. Williams H. Another vehicle-controlled study of 1% pimecrolimus in atopic dermatitis: how does it help clinicians and patients, and is it ethically sound?. Arch Dermatol 138 (2002) 1602-1603
6. Eichenfield L.F., Lucky A.W., Boguniewicz M., Langley R.G., Cherill R., and Marshall K. 1% pimecrolimus cream for atopic dermatitis. Arch Dermatol 139 (2003) 1369-1370
7. Adetugbo K., and Williams H. How well are randomized controlled trials reported in the dermatology literature?. Arch Dermatol 136 (2000) 381-385